chrisvoncsefalvay/vaers-outcomes huggingface dataset:
feel his chest and neck hurting; feel his chest and neck hurting; feeling really sick; feeling tired; arms hurting; head hurting/ neck and all around head area, hurting real bad; This is a spontaneous report from a contactable consumer (patient). A 30-year-old male patient received second dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: not provided), via an unspecified route of administration on 10Jan2021 at single dose for COVID-19 immunization (reported as "I guess to protect myself from other people, to protect myself"). There were no medical history and concomitant medications. The patient took his first dose on 20Dec2020, 3 weeks from there, he took the second on 10Jan2021 (reported as "it was 10th it was Sunday morning when I took it"). The patient reported that he had his second dose on Sunday morning (10Jan2021) and started feeling tired last Monday (11Jan2021). Then on 12Jan2021 (reported as "yesterday" at the time of reporting), he started to feel his chest and neck hurting. The patient stated that he woke up in the middle of the night (Sunday night) and Monday morning, he was feeling really sick so he called out rest all day on Monday (11Jan2021). Then patient woke up yesterday morning (12Jan2021) feeling good then probably about 6 o'clock last night he started feeling tired, like real bad tired and he got home. Patient lied down and woke up in middle of night, his chest, arms and head were hurting. His neck and all around head area were hurting real bad. The events were assessed as non-serious. The patient does not have the lot number but stated that it was the Pfizer vaccine. When the patient was asked if still experiencing tiredness and chest hurting, he stated "When I started, that was last night on I will go with the 12 before midnight 12 (not clear). Yes right now yeah. This is the first time my chest and my arms and my neck and like all that has been hurting, started last night". When asked for the treatment, the patient answered "I took Ibuprofen to calm it down a little bit. I took Ibuprofen if you count that as a treatment". Outcome of the events was unknown.  Information about lot/batch number has been requested.
Patient had been to the doctors office and came to us.  Seemed to be a typical localized reaction to the immunization with heat, pain, some swelling, and slight discomfort from the shoulder to the elbow.
tested positive for COVID-19 with fever 13 day (low grade) and flu like symptoms; tested positive for COVID-19 with fever 13 day (low grade) and flu like symptoms; This is a spontaneous report from a contactable consumer. An adult male patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine) on an unspecified date (lot number was not reported) as dose 2 single and on an unspecified date (lot number was not reported) as dose 1, single both via an unspecified route of administration for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient has not been diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 26Sep2021 the patient tested positive for COVID-19 with fever 13 day (low grade) and flu like symptoms. The event resulted in a doctor or other healthcare professional office/clinic visit. The patient did not receive treatment for the events. The patient recovered from the events on an unknown date in 2021.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
I had no adverse affects to my first SHINGRIX vaccine received in June of 2018. The day after my second vaccination I felt like I had the full blown flu. Body aches, chills, fatigue. This got worse as the evening progressed and lasted thru the night. I had teeth chattering chills to throw the sheet off warmth. I had to change my tee shirt in the night when I woke up to a sweat dampened shirt. By late morning the next day I felt fine. I also had a rash and minor swelling at the injection site.
I started becoming dizzy 10 to 15 minutes after I received the first dose of the vaccine. I remained dizzy for the next 4 days feeling like I was on a boat. By the 6th day it was even worse. It has lasted over 3 weeks now and is ongoing. I have been trying the epley maneuver as I was instructed to do so by my doctor and take my allergy medication (Flonase) to potentially decrease inflammation as well as take tylenol. I will be going to see an ENT specialist next week to try to get some relief. It has been horrible and I haven't been able to work full time for the last 2 weeks.
the patient did not experience additional symptoms; a patient received unspecified dose in VAQTA immunization series that was improperly stored; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 07-NOV-2019, the patient received improperly stored hepatitis a vaccine, inactivated (VAQTA) injection (lot # S010727, expiry date: 26-JUL-2020) (exact dose and route of administration were not reported) for prophylaxis.  Storage temperature was 10.57 Celsius degree during the time frame of 15 minutes. Previous temperature excursion was 9.94 Celsius degrees for 15 minutes, 10.1 Celsius degrees for 15 minutes and 13.29 Celsius degrees for 45 minutes. The digital data logger was involved. The patient did not experienced additional symptoms.
X-ray showed something in reference to arthritis; Rash; Dizziness; Severe muscle pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ARTHRITIS (X-ray showed something in reference to arthritis), RASH (Rash), DIZZINESS (Dizziness) and MYALGIA (Severe muscle pain) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included Muscle pain since an unknown date. Concomitant products included CHLORTHALIDONE and EZETIMIBE for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced RASH (Rash), DIZZINESS (Dizziness) and MYALGIA (Severe muscle pain). On an unknown date, the patient experienced ARTHRITIS (X-ray showed something in reference to arthritis). On 26-Feb-2021, RASH (Rash) had resolved. At the time of the report, ARTHRITIS (X-ray showed something in reference to arthritis), DIZZINESS (Dizziness) and MYALGIA (Severe muscle pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood pressure measurement: normal normal. In 2021, X-ray: (Inconclusive) showed something in reference to arthritis..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient used Aloe Vera to rub down on the rash to treat and it went away the next day. She is been taken off from her cholesterol medication by her doctor to check if there will be change in her muscle pain.
BlurredVision, Headache, CoughWheeze, HYPERtension, Syncope, shortness of breath Narrative:
My daughter was a fluent speaker without any problems at all.  She now has a definite stutter.  It was not there before this shot.  It has progressively gotten worse over the course of the last week, so we want to report the incident.  Hopefully it will go away.  Very scary as this child had absolutely no problems before the shot and now cannot start sentences without a prolonged stutter.  She is still very alert, thank God.
Side effects after booster dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects after booster dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects after booster dose). At the time of the report, VACCINATION COMPLICATION (Side effects after booster dose) outcome was unknown.            No concomitant medications were provided. No treatment medications were reported.   This case was linked to MOD-2021-398716 (Patient Link).
Initial information received on 10-Aug-2018 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 6 months old patient (gender not reported) who was vaccinated with a 0.5 ml dose of QUADRACEL (Batch number: B5325BA) via intramuscular route in the left thigh on 09-May-2018. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PREVENAR for Immunisation; and CINNARIZINE for Product used for unknown indication on an unknown date. It was a case of actual medication error due to inappropriate age at vaccine administration because QUADRACEL given to a six-month old baby child. No adverse event symptoms have been reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Documents held by the sender: None.
Post vaccination syncopal episode immediately following injections and lasting a couple of seconds. Pt quickly recovered and was given apple juice and two lollipops and returned home. Menactra and Adacel were administered during the patient's routine well child check. VS prior to injection (5/17/21) T-98.3 P-73 R-18 BP-108/60 SpO2 98% on RA Ht: 59.2 inches Wt: 101 lbs. Pt's father called today reporting pt was sent home from school with c/o dizziness, nausea, headache and temp 99.2-F (5/18/21 11:50AM). Encouraged rest, fluids, APAP per mfg directions, continue to monitor.
I contracted Covid-19 even with being vaccinated. I am thankful for being vaccinated otherwise I belive my symptoms would have been a lot worse. I started out not feeling well at work after lunch. I felt really tired,weak, and had a horrible headache. By that night I could not stay awake and had a small fever of 99.5. The next day I had horrible body aches, still a severe headache and just wanted to sleep all day. Unfortunately I was unable to isolate from everyone in my house because my 7 year old was sick as well. Thankfully his illness only lasted 3 days. By the third day of my illness I went to get tested since my symptoms were not improving. My test came back Positive for Covid-19 on January 2, 2022. Around the 4th day I lost my taste and smell and had severe nausea for 3 days.  I also had heavy pressure on my chest that has yet to subside.
Shingrix was administered on 11/14/20 on 11/16/20 patient broke out in rash on body. She did see her doctor who prescribed on 11/17/20, prednisone 5mg, (alahist anD benadryl
Flu Mist vaccine on 10/03/2009 woke Monday 10/5/2009 with uticaria rash on waist and trunk
dizziness and fainted, shivers/chills, 4 x episodes of break through seizures
An hour after Pfizer vaccine administration, the parents of the 16 year old patient returned to the pharmacy and reported that their daughter was complaining of trouble breathing in the parking lot.  The immunizing tech asked the parents to bring the patient back to the pharmacy.    The patient returned and while crying and gasping for air, she reported that it felt as if someone was constricting her throat.  She also complained of stiff fingers and feeling numbness/tingling in her upper extremities.    Assuming anaphylactic reaction, one dose of epinephrine was administered.  The patient said she felt slightly better after the first dose but then 2 minutes later, said her breathing was getting worse, and again described feeling her throat tightening.  Five minutes later, a 2nd dose of epinephrine was administered.   The patient was taken to the hospital by paramedics.
Woke up at 1:30 am with shivers and vomited.  Felt dehydrated.  Woke up one hour later sweating and vomited.  Repeat back and forth cycle until 7am.  Feeling much better now.  Just achy.
Approximately seven hours after the time the vaccine was administered, the injection site became swollen and red (~2 inches in diameter). The following day, on January 9th, the injection site also began itching.
Breakthrough case admission after 2 vaccines Pfixer 2/24/21 Lot# EN6198;  Pfizer 3/17/21 Lot# EN6199
24APR97 930PM observed by aunt-gen shaking, limp no verbal response, incontinent of urine;took to ER hosp put on ATB for 10 days;dx new onset sz;MD office stated isolated sz-did not feel was vaccine related;
tired all the time; vision was blurred; migraine; want to lie down/ he is not same after getting vaccine; doesn't not have energy; sick for 3 days; diarrhea; vomiting; feverish; totally totally whole body was achy; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (vision was blurred), MIGRAINE (migraine), MALAISE (want to lie down/ he is not same after getting vaccine), ASTHENIA (doesn't not have energy) and ILLNESS (sick for 3 days) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN, LISINOPRIL, GLIMEPIRIDE, ROSUVASTATIN CALCIUM (CRESTOR), PIOGLITAZONE HYDROCHLORIDE (ACTOS), CANAGLIFLOZIN (INVOKANA [CANAGLIFLOZIN]), RIVAROXABAN (XARELTO), METOPROLOL TARTRATE and AMIODARONE for an unknown indication.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced VISION BLURRED (vision was blurred), MIGRAINE (migraine), MALAISE (want to lie down/ he is not same after getting vaccine), ASTHENIA (doesn't not have energy), ILLNESS (sick for 3 days), DIARRHOEA (diarrhea), VOMITING (vomiting), PYREXIA (feverish) and MYALGIA (totally totally whole body was achy). On an unknown date, the patient experienced FATIGUE (tired all the time). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency and CYANOCOBALAMIN (B 12) for Loss of energy, at an unspecified dose and frequency. On 02-Mar-2021, VISION BLURRED (vision was blurred), MIGRAINE (migraine), MALAISE (want to lie down/ he is not same after getting vaccine), ILLNESS (sick for 3 days), DIARRHOEA (diarrhea), VOMITING (vomiting), PYREXIA (feverish) and MYALGIA (totally totally whole body was achy) had resolved. At the time of the report, ASTHENIA (doesn't not have energy) and FATIGUE (tired all the time) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       This case was linked to MOD-2021-076282 (Patient Link).
January 21 hemifacial spasms started on left side of face and continued for a week, progressed to tingling on left side of body.  Was evaluated January 28th in urgent care.  Tingling and numbness on left side of face, left arm, left leg and foot continued most days for approximately 3-4 months and then was more occasional for another 3 months.
This literature study report was received from a literature article. The author stated that newly diagnosed HIV-positive individuals are 35 to 100-fold more susceptible to Streptococcus pneumoniae infection compared to non-infected individuals. Therefore, the PPV23 has previously been recommended, though efficacy and effectiveness of vaccination remains controversial. Early severe B cell dysfunction is a central feature of HIV infection. The specific nature of the immune cells involved in the production of protective antigen-specific antibodies in HIV-positive individuals remains to be elucidated. There were three goals in this study. First, to elucidate the immunogenic response to PPV23 in newly diagnosed HIV-positive individuals. Second, to evaluate whether is it potentially beneficial to provide 6-12 months of HAART (highly active anti-retroviral therapy) to suppress viral load and potentially improve immune function before PPV23 vaccination in newly diagnosed HIV-positive individuals with CD4<200. Third, to elucidate the phenotypic distribution of PPS-selected B cells in newly diagnosed HIV-positive individuals, dependent on CD4 count, compared to HIV-negative individuals. This case concerns a patient of unknown age and gender. Forty-three pneumococcal polysaccharide vaccine naïve newly diagnosed HIV-positive volunteers participated in the open observational study. HIV-positive individuals were stratified according to CD4 counts. Twenty two HIV-negative volunteers participated in this study. All volunteers were vaccinated with PNEUMOVAX 23 (dose and route of administration not provided) on day 0. All adverse events to vaccination were recorded. On an unknown date one patient experienced Arthus-type reaction. The outcome of the events was unknown. The authors considered the event to be related to PNEUMOVAX 23. The authors concluded that despite CD4-dependent pneumococcal polysaccharide-specific deficiencies in newly diagnosed HIV-positive patients, vaccination was beneficial based on opsonophagocytic titers for all newly diagnosed HIV-positive groups. In HIV-positive patients with CD4<200 cells/microL, 6-12 months of HAART did not improve opsonophagocytic titers or antibody concentrations. Based on these findings, immunization with the PNEUMOVAX 23 should not be delayed in newly diagnosed HIV-positive patients with CD4<200 cells/microL. Additional information has been requested.
Moderna Covid-19 vaccine EUA  8 days after the shot I got hives just below the vaccination site. The area is warm to the touch and slightly raised and itchy. Applied cortisone cream and itching stopped. No fever.
A report has been received from a pharmacist, concerning a female patient. The patient's relevant medical history, concomitant medications and concurrent diseases were unknown. On an unknown date, the patient received nasal FLUMIST Quadrivalent, 0.2 milliliters. Single nostril administration was reported. The outcome of the event of single nostril administration was unknown. The report was considered to be non-serious by the company physician.
pt recv vax 15NOV96 & on 11APR97 pt exp a breakthrough w/about 15 lesions;the reporter also noted that pt sibling had similar exp p/vax WAES97041944;
On 10/17 patient came by the pharmacy seeking OTC treatment for sore arm noticed after vaccine administration 2 weeks prior. Reported after vaccine was administered, no pain with the Injection. Next couple of days, described tenderness as expected, no swelling. Noticed 3 to 4 days after administration, she was not able to lift her arm above shoulder and described the pain "similar to a sore muscle", not a nerve pain, but tingling-like sensation. Taking ADVIL occasionally and warm compress to alleviate. Follow up call on 10/18, indicated her arm was feeling better, appreciated the concern and plans to report VAERS. Let the patient know if the pain is not getting better, to see PCP.
SORE ARM; SLIGHT HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination.  The batch number was not reported. Per procedure no follow up will requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced sore arm, and slight headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sore arm and slight headache was not reported. This report was non-serious.
Information has been received from an MD concerning a 25 year old " healthy" female who on 05/10/2004 was vaccinated with a dose of varicella virus vaccine, live. There was no concomitant  medication. On 05/24/04, the pt developed a rash. She had 3 papules at the injection site and one broken vesicle on her chest. Unspecified medical attention was sought and no Tx was required. No product quality complaint was involved. Additional information has been requested.
Severe itching started April 4, 2021 on my stomach .  Affected areas include chest buttocks thighs and legs.  Dr prescribed calamine lotion and benadryl topical.  Just starting getting relief today.
Information has been received concerning a pt who was vaccinated on 05/30/97 and 06/30/97 with first and second doses of varicella virus vaccine. there were no illnesses at the time of vaccination. On 05/09/2000 the pt experienced a full blown case of chickenpox. It was noted that she was covered with pustules. Additionally, the pt believed that she was exposed to varicella through her infant son who had not been vaccinated and recently had wild type varicella. The pt recovered on 05/19/00.
The day of vaccination, drove off , I was fine, went to my eye appointment. However the morning after...Initially woke with the sniffles, later within the hour, then my body started to have aches all over, felt enormous amount of fatigue, feeling lethargic, feelings of chills , then feverish, but with no temperature, stayed at 98.1 for the course of the day, my left arm location for vaccination , I have extreme pain  I found that Tylenol is slightly a remedy for me
Patient has never had missed menses but reports that she has had irregular menses since this shot. She also has had dizziness and new onset migraines.
The patient was sitting in the waiting area following her vaccination when shortly after receiving the vaccine, her mother flagged us down and said that she lost her vision. She was describing feeling unwell. I had her lay down on the floor in the immunization booth and her mother elevated her legs. I asked her to describe her symptoms and she said that she just saw all white. I asked if she wanted me to check her blood pressure and I had her sit up on the floor and it was low around 75/53 with a pulse of 53 but not sure how accurate it was since she was sitting on the floor. She fluctuated from starting to feel better and feeling unwell again and her vision going out again. I asked if they wanted me to call 911 and her mother said she wasn't sure what to do, if she should take her to an urgent care. I said that it would be best if she was seen in an emergency room where they can better respond to this kind of situation. The patient was able to get up and walk with her mother's assistance. I was going to help walk her out but she said that she was okay walking out with her mother's help. About 10 minutes later, I called the patient to see how she was doing. Her mother said that she was doing okay and that they were on their way to the hospital just to make sure that she was checked and everything was okay.